Loveland, OH, United States of America

E David Alten


 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: E David Alten – Innovator in Antibody Fragment Technology

Introduction: E David Alten is a notable inventor based in Loveland, Ohio, recognized for his contributions to the field of biotechnology. With two patented innovations to his name, Alten has focused on developing methods and compositions related to single chain antibody fragments that target tumor-associated glycoprotein 72 (TAG-72). His work aims to provide therapeutic options for cancer treatment by harnessing the specificity of antibody fragments.

Latest Patents: Alten’s latest patents include innovative methods and compositions related to single chain antibody fragments that specifically bind to the sialyl-Tn epitope of the tumor-associated glycoprotein 72 (TAG-72). These significant inventions contribute to the growing field of immunotherapy, offering potential advancements in cancer diagnostics and treatments.

Career Highlights: E David Alten has established himself in the biotechnology sector through his work at the Ohio State Innovation Foundation. His research and development efforts are driven by a commitment to improving medical outcomes through innovative biotechnology solutions. The recognition of his patents underscores his ability to translate scientific advancements into viable applications.

Collaborations: Throughout his career, Alten has collaborated with esteemed colleagues, including Thomas J Magliery and Brandon J Sullivan. These partnerships highlight the collaborative nature of innovation in the field of biomedicine, reflecting the importance of teamwork in advancing research and development.

Conclusion: As an inventor, E David Alten continues to make strides in the biotechnology domain through his patented work on antibody fragments targeting tumor-associated glycoproteins. His contributions not only enhance our understanding of cancer biology but also pave the way for new therapeutic strategies. With a solid foundation in research and innovation, Alten is poised to influence the future of medical science significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…